What is Alcon Inc. (ALC)?

Alcon Inc. (ALC) is a stock in the Healthcare sector, Medical - Specialties industry. View full analysis on Stocks360.

What is the current price of ALC?

The current price of ALC is $69.42. Prices are updated in real time on Stocks360.

What is ALC's price-to-earnings (PE) ratio?

ALC's trailing twelve-month PE ratio is 53.40, based on current price and earnings per share data available on Stocks360.

What is ALC's market capitalization?

ALC's market capitalization is $33,557,628,000.00, placing it in the large-cap tier.

Does ALC pay a dividend?

Yes. ALC has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Alcon Inc. (ALC)

Stock analysis · NYSE · Healthcare · Medical - Specialties

$69.42

Market Cap

$33.56B

PE (TTM)

53.40

EPS (TTM)

N/A

Dividend Yield

0.52%

Beta

0.73

Day Range

$69.30 – $70.01

52-wk Range

$61.84 – $87.64

Avg Volume

N/A

Volume

1.20M

Alcon Inc. (ALC) is a publicly traded company in the Healthcare sector. Latest price: $69.42. Market cap $33.56B. Trailing PE 53.40. Dividend yield 0.52%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $74.82 2026-10-27 · $69.42 (-7.22%)

Earnings

Most Recent

Aug 10, 2026

EPS $0.84 vs est. $0.77

Beat by $0.07

Next Earnings

Nov 10, 2026

EPS estimate $0.89

Proprietary Signals

Signal snapshot temporarily unavailable.

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit prob…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	53.40×
P/S (TTM)	3.10×
P/B	1.56×
P/FCF (TTM)	19.94×
EV / EBITDA	13.54×
EV / Sales	3.47×
Earnings Yield	1.89%
Free Cash Flow Yield	5.02%
Dividend Yield	0.52%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$37.50B
Revenue (TTM)	$10.81B
Net Income (TTM)	$634.99M
Free Cash Flow (TTM)	$1.82B
Net Debt	$3.94B
Working Capital	$3.46B
Gross Margin	56.45%
Operating Margin	9.87%
Net Margin	5.92%
Return on Equity	2.91%
Return on Invested Capital	3.24%